La Jolla Pharmaceutical (LJPC) Misses Q4 EPS by 22c
Tweet
Share
E-mailGet Alerts LJPC Hot Sheet
Price: $6.22 --0%
Financial Fact:
Loss from operations: -15.62M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Loss from operations: -15.62M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
La Jolla Pharmaceutical (NASDAQ: LJPC) reported Q4 EPS of ($0.96), $0.22 worse than the analyst estimate of ($0.74). Revenue for the quarter came in at $234 thousand versus the consensus estimate of $210 thousand.
For earnings history and earnings-related data on La Jolla Pharmaceutical (LJPC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Investing.com’s stocks of the week
- DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
